Effectiveness of individualized homoeopathic medicines vs Arsenicum Sulphuricum Flavum in improving the quality of life among vitiligo patients: An open label randomised controlled clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- It is expected that there will be repigmentation in depigmented area of skin with the individualized homoeopathic medicines compared to Arsenicum Sulphuricum Flavum in vitiligo.
研究概览
简要总结
This study compares the effectiveness of individualized homeopathic medicines and Arsenicum Sulphuricum Flavum in treating patients with Vitiligo, aged 05 years- 65 years. Patients will be randomly assigned to receive either individualized homeopathic medicines or Arsenicum Sulphuricum Flavum. The study will measure the outcomes using VASI (Vitiligo Area Severity Index) and DLQI (Dermatology Life Quality Index) scores. The primary goal is to compare the effectiveness of these two approaches in managing vitiligo, improving quality of life, and reducing disease severity. The results will provide valuable insights into the effectiveness of homeopathic approaches in treating Vitiligo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 5.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patient suffering from vitiligo.
- •2.Both sexes of age group 5 years to 65 years.
- •3.Patient willing to give voluntary written informed assent and consent (greater than 18 years).
排除标准
- •1.Vitiligo patients suffering from any life-threatening illness who are terminally ill, under immuno-suppressive treatment or self-reported immuno-compromised state.
- •2.Patients of malignancy or too sick for consultation.
- •3.Diagnosed case of mental illness / psychiatric/ other uncontrolled/ life threatening illness affecting quality of life/any organ failure.
- •4.Pregnant ladies are excluded.
- •5.Unwilling to take part and not giving consent to join the study.
- •Patients unable to comply with the study protocol.
- •Substance abuse and or dependence.
结局指标
主要结局
It is expected that there will be repigmentation in depigmented area of skin with the individualized homoeopathic medicines compared to Arsenicum Sulphuricum Flavum in vitiligo.
时间窗: At baseline (0 weeks) and after 9 months(36 weeks)
次要结局
- It is expected that there will be improvement in patient’s outcome and general well being, without any substantial medicinal adverse effects hence an improvement in quality of life (DLQI) & significant reduction in VASI scores and Re-pigmentation on hypopigmented/ depigmented patches.(At baseline (0 weeks) and after 9 months (36 weeks))
研究者
Dr Ankita Jain
Dr B R Sur Homoeopathic Medical College Hospital And Research Centre, Nanakpura Motibagh